Colorectal cancer is one of the most common causes of death from cancer. However, if it is detected at a very early stage, there is an over 90% chance of survival. Adenomatous polyps, that have the potential to transform into cancer, tend to bleed frequently. It is known that their early removal reduces the risk of colorectal cancer1.
The BIONEXIA® FOBplus rapid test allows the detection in stools of human hemoglobin potentially linked to adenomatous polyps. Without automatically pointing to cancer, a positive test result indicates a disorder which should be investigated further.
The BIONEXIA® FOBplus test is much more sensitive than Guaiac-based tests2 in correlation with clinical diagnosis.
Please consult your local bioMérieux representative for product availability in your country